Santen SA
Budget
€50 — €0
EP Access
0
accredited persons
Staff
1
0.5 FTE
EU Grants
None
Mission & Goals
Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world. We’re the ophthalmology market leader in Japan. We’ve been active in the European market since 1994 and are enjoying strong growth in EMEA (Europe, Middle East, Africa) and worldwide. We’re passionate about improving eye health and vision for patients and making beneficial treatments accessible to patients and healthcare systems. With our sole focus being ophthalmology, we can assess, respond and act quickly in this specialist field where we have deep knowledge and experience.
EU Legislative Interests
General pharmaceutical legislation, health technology assessment and market access, paediatric regulation, ATMP regulation, digital fairness act, sustainable development goals.
Communication Activities
Santen-sponsored events: 06.11.2025: Outdoor Classroom Day & Children's Eye Health - Awareness Event
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EUCOPE Transform Alliance Europan Organization for Rare Diseases (EURORDIS)
Organisation Members
N/A
Connected Legislation
Commissioner Meetings
No recorded meetings with EU commissioners.